A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Why healthcare marketers need more transparency in audience targeting Healthcare marketers are under pressure to do more than deliver reach. They need to show that their targeting strategy reflects real patient and provider behavior, stands up to scr...